Forte Biosciences, Inc.
Price Action
Technical Summary
WEAKENINGForte Biosciences, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 38), showing significant lag compared to the market leaders. Earnings growth of 9% provides fundamental context to the price action. Investors should exercise caution due to high volatility (98% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $17.94 | +18.86% | ABOVE |
| 50 SMA | $22.50 | -5.23% | BELOW |
| 100 SMA | $25.50 | -16.38% | BELOW |
| 150 SMA | $25.60 | -16.72% | BELOW |
| 200 SMA | $22.57 | -5.54% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is FBRX in an uptrend right now?
FBRX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is FBRX overbought or oversold?
FBRX's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.
Is FBRX outperforming the market?
FBRX has a Relative Strength (RS) Rating of 38 out of 99. FBRX is currently lagging the broader market.
Where is FBRX in its 52-week range?
FBRX is trading at $21.32, which is 60% of its 52-week high ($35.80) and 46% above its 52-week low ($9.10).
How volatile is FBRX?
FBRX has a Beta of 0.91 and 52-week volatility of 98%. It's less volatile than the S&P 500 - generally more stable.